Opendata, web and dolomites

BestTreat SIGNED

BestTreat – Building a Gut Microbiome Engineering Toolbox for In-Situ Therapeutic Treatments for Non-alcoholic Fatty Liver Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BestTreat project word cloud

Explore the words cloud of the BestTreat project. It provides you a very rough idea of what is the project "BestTreat" about.

educate    world    sectoral    disciplinary    microbiology    training    clinical    nafld    monitoring    bioinformatics    academic    young    human    drug    leads    molecular    education    modern    overcomes    characterization    live    therapeutics    network    genome    skills    esrs    identification    competencies    inter    life    sciences    beneficial    data    cell    industry    complemented    cross    tissue    complete    functional    samples    trains    microbial    interdisciplinary    throughput    organisms    upcoming    sustainable    establishing    links    multidisciplinary    biology    scientists    15    optimally    technologies    translate    fosters    biotherapeutics    metabolically    combine    signatures    companies    train    transferable    uncover    prediction    microbiome    computer    hands    metabolism    science    discovery    types    ultimately    skilled    metabolic    therapeutic    therapies    generation    model    forming    entrepreneurial    qualified    screening    treatments    barriers    risk    decennium    improvements    questions    medicine    medical    besttreat   

Project "BestTreat" data sheet

The following table provides information about the project.

Coordinator
LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOLL-ISTITUT 

Organization address
address: BEUTENBERG STRASSE 11A
city: JENA
postcode: 7745
website: http://www2.hki-jena.de/rz/hki_i00.htm

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 4˙134˙155 €
 EC max contribution 4˙134˙155 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2018
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-09-01   to  2022-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOLL-ISTITUT DE (JENA) coordinator 758˙365.00
2    ITA-SUOMEN YLIOPISTO FI (KUOPIO) participant 842˙417.00
3    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) participant 595˙044.00
4    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 531˙239.00
5    RIJKSUNIVERSITEIT GRONINGEN NL (GRONINGEN) participant 531˙239.00
6    CHR. HANSEN A/S DK (HOERSHOLM) participant 297˙522.00
7    CLINICAL-MICROBIOMICS AS DK (KOBENHAVN) participant 297˙522.00
8    AFEKTA TECHNOLOGIES LTD FI (SIILINJARVI) participant 280˙805.00
9    BIOFACTION KG AT (WIEN) partner 0.00
10    BRAVAD PRODUCTION APS DK (KOBENHAVN) partner 0.00
11    FRIEDRICH-SCHILLER-UNIVERSITAT JENA DE (JENA) partner 0.00
12    GUBRA APS DK (HORSHOLM) partner 0.00
13    SHANGHAI SIXTH PEOPLE'S HOSPITAL CN (SHANGHAI) partner 0.00
14    UDATHA DASARADHI SE (OSLO) partner 0.00

Map

 Project objective

BestTreat fosters education of ESRs in a project to uncover microbiome signatures for risk prediction and monitoring of NAFLD and to contribute to the development of therapeutic treatments based on metabolically beneficial microbial consortia. It trains 15 ESRs at world-leading academic institutions and companies, thus forming strong interdisciplinary links between industry, life and medical sciences, and end-users. BestTreat aims to train a new generation of highly qualified ESRs with entrepreneurial competencies in modern Life Sciences through state-of-the-art research projects. The projects focus on the identification and functional characterization of microbial consortia that contribute to metabolic control, and the application of this knowledge to develop novel leads for drug discovery and therapies for NAFLD. The new field on microbiome based therapeutics requires highly skilled scientists with interdisciplinary knowledge on medicine, systems biology and computer science, as well as hands-on experience with several types of tissue samples and model organisms that can optimally translate their research findings into sustainable improvements in clinical practice. BestTreat overcomes current barriers by establishing a strong, multidisciplinary and inter-sectoral training network, developing technologies tailored to solve key questions in human metabolism, microbiology and bioinformatics. The BestTreat programme will exploit recent developments in high-throughput and genome-wide screening technologies, combine these with modern molecular cell biology and systems biology approaches and ultimately translate the data into new leads for the discovery of live biotherapeutics. This specific cross-disciplinary training program will educate young scientists to the next level needed to advance this research field for the upcoming decennium. The training programme will be complemented with a complete set of transferable skills.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BESTTREAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BESTTREAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

CHANGE (2019)

Cultural Heritage Analysis for New GEnerations

Read More